Levocetirizine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06282 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 3 | brachydactyly-syndactyly syndrome | KG + DL |
| 4 | osteoarthritis susceptibility | KG + DL |
| 5 | common cold | KG + DL |
| 6 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 7 | osteoarthritis | KG + DL |
| 8 | myosclerosis | KG + DL |
| 9 | brachyolmia | KG + DL |
| 10 | gout | KG + DL |
| 11 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 12 | headache disorder | KG + DL |
| 13 | trigeminal autonomic cephalalgia | KG + DL |
| 14 | multiple endocrine neoplasia | KG + DL |
| 15 | WHIM syndrome | KG + DL |
| 16 | arthropathy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.